The following adjustment was made today on Novartis (NVS). All prices include IB commissions.
This is the second position on NVS.
| Criteria | Value |
|---|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 10 |
| Fair Value Estimate | $69.00* |
| Target Buy Price | $55.20 |
| Target Margin of Safety | 20.00% |
| Actual Buy Price | $52.50 |
| Actual Margin of Safety | 23.91% |
*Fair Value was lowered from $71 to $69 since inception which lowered my 26.06% Margin of Safety to 23.91%.
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 7/27/2012 | NVS | Continued Trade | STO 1 Sep12 60.00 Call @ 0.54 | $54.25 |
Current Position Summary
| Cost Basis | ($5,500.00) |
| Income Generated | $192.19 |
| Percent Income Generated | 3.49% |
| Annualized Income Generated | 6.02% |
| Net Profit If Assigned | $692.19 |
| Percent Return If Assigned | 12.59% |
| Annualized Return If Assigned | 21.67% |
| Days Held to Expiration | 212 days |
Trade History
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 2/22/2012 | NVS | CSP Margin Used | CSP 100 NVS @ 55.00 | ($5,500.00) | ||
| 2/22/2012 | NVS | Initial Put Option | STO 1 Mar12 55.00 Put @ 0.79 | Exercised | $78.97 | |
| 3/16/2012 | NVS | CSP Margin Returned | CSP 100 NVS @ -55.00 | $5,500.00 | ||
| 3/16/2012 | NVS | Stock Assigned | EX 1 Mar12 55.00 Put @ -55.00 | ($5,500.00) | ||
| 3/19/2012 | NVS | Continued Trade | STO 1 May12 57.50 Call @ 0.59 | Expired | $58.97 | |
| 7/27/2012 | NVS | Continued Trade | STO 1 Sep12 60.00 Call @ 0.54 | $54.25 | ||
| 9/21/2012 | NVS | Totals | ($5,500.00) | $192.19 | ||
| DTE | 212 | Percent Income/Annualized | 3.49% | 6.02% |
